Our history
Group Development
Foundation of Medica, a consultancy company for the innovation and development of new blood purification products
Product Development
Launch of the first electromedical equipment for CVVH (HP150/300 blood pump and EQUALine module for fluid balancing), solvent dosing equipment and seal testing for clean rooms
Group Development
Acquisition of Tecnoideal, a company specialising in automatic assembly technologies for plastic medical devices
Group Development
Acquisition of Menfis Biomedica, a company specialising in the development of equipment for Urology and Diagnostic Gastroenterology
Product Development
Production of the first membrane extrusion line for blood purification
Product Development
Launch of of EQUAsmart, the first electromedical device for CRRT manufactured by Medica
Group Development
Start of construction of SarMed filter production plant
Product Development
Launch of of CARDIOsmart™, an electromedical device for the treatment of Congestive Heart Failure
Product Development
Development of a hollow fibre membrane specifically for oxygen humidification
Group Development
Medica S.r.l. becomes Medica S.p.A.
Product Development
- Development of of Carpe Diem, an electromedical device designed for neonatal/paediatric use
- Production at SarMed's of the first Dialysis Filters with automatic assembly line
Group Development
Acquisition of Medica Méditerranée, a company specialising in component moulding and medical device assembly
Group Development
Medolla / Mirandola earthquake
Product Development
Sale of Carpe Diem project to Bellco (now Medtronic)
Group Development
Completion of Medica and Tecnoideal headquarters, completely rebuilt after the 2012 earthquakes
Product Development
- Development of a hollow fibre membrane specifically for plasmapheresis
- FDA approval for the US market for point-of-use filters
Product Development
Development of a hollow fibre membrane specifically for 'cascade filtration’
Product Development
Launch of VITAsmart™, a transplantation-specific electromedical device for organ perfusion
Group Development
Medica becomes part of the Graphene Flagship (EU consortium) to coordinate the Graphil project to develop a water filter suitable for emerging contaminants and reduce the use of plastic bottles
Group Development
- Acquisition of THF, a company specialising in the construction of radio frequency welding machines
- Medica is listed on the Euronext Growth Milan market.
Group Development
- Acquisition of 51% of Spindial, a company specialising in the marketing and technical support of medical devices for hospital and home dialysis and the management of dialysis centres.
- Acquisition of Slom, a precision mechanics workshop
- opening of the Medica USA Inc, Medica Advanced Technology Ltd (UK) and Medica GmbH (DE) subsidiaries
Product Development
Acquisition of important patents from Exosomics, a company specialising in Oncological diagnostics
Group Development
Purchase contract of assets to manufacture blood and water filter products with Evoqua Water Technologies (NYSE: AQUA), an industry leader in mission critical water treatment solutions. Evoqua will retain distribution rights to the water filter product line.